Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

CSE:SONA - Post by User

Sona Nanotech Inc > Sensitivity and Specificity Matter

<< Previous

Bullboard Posts

Next >>

Comment by Hightide22on Sep 29, 2020 12:18pm

139 Views

Post# 31635348

RE:Sensitivity and Specificity Matter

LuckyMeLuckyYou wrote: As per Health Canada , for test to be approved need no less than 90% sensitivity and no less than 95% specificity.

" Sensitivity and specificity values below these values will produce too many false positive and false negative results. These tests will not be authorized, regardless of any other factors."

REALLY, U SURE ABOUT THAT?

Health Canada considers the following to be unacceptable for authorization: